RBFOX2 and acute myeloid leukemia: Consistent with our findings in the xenograft model using AML cell lines, RBFOX2 KD significantly inhibited cell growth, promoted myeloid differentiation and substantially prolonged mouse survival in the AML PDX model (Fig. 5f–h and Extended Data Fig. 7j–n).